Miami alum Michael Irvin reminded fans that 'coke don't last five hours' after some speculated he was high during the championship game
"GLP-3" breakthrough drug retatrutide by Eli Lilly shows major weight loss in clinical trials. The triple-agonist medication targets three hormones, with positi...
Seattle schools face a Department of Education privacy investigation over health survey asking students about gender identity, with data reportedly shared with ...
The ex-Nickelodeon actor Tylor Chase has been spotted sleeping on the streets of Riverside, California, in recent weeks battling drug issues.
With Serena Williams, Amy Schumer, Andy Cohen, Meghan Trainor and more stars giving the various weight loss medicines a shot, it'd be easier to catalog which ce...
A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research.
In a new study in rats, Stanford Medicine scientists used ultrasound-activated nanoparticles to deliver ketamine and anesthetics to precise targets in the body.
A 30-year-old former substitute teacher was sentenced to 10 years in prison on Wednesday.
Kevin Spacey said he 'literally' has no 'home,' is living out of his suitcase in various hotels and Airbnbs while working as a lounge singer in Cyprus
Ozempic was just the beginning.
Paris Jackson opens up about living with permanent consequences of drug addiction, including a perforated septum that affects her breathing and music career.
Russian Foreign Minister Sergey Lavrov has condemned US strikes off the coast of Venezuela and urged Washington to focus on Belgium instead
Middle-class Indians trying to lose weight are embracing drugs such as Mounjaro, which was already widely used in a country that has been called the world’s d...
Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, will agree to sell their drugs to ...
Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.
NBC News confirms the Trump administration is preparing to announce a deal to sell Wegovy and Zepbound for as little as $149 a month for the lowest doses, accor...
Shares of Cytokinetics, which targets medicines for specialty heart diseases, have jumped about 69% over the past three months and are up 31% year to date.
Since Vancouver opened its first supervised injection site in 2003, overdose deaths increased 996.5%, from 229 vs 2,511.
